Skandinaviska Enskilda Banken AB (publ)

Position in ACLX — Arcellx, Inc.

CIK 1534653 STOCKHOLM, V7

Position in ACLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,755,680

New position

Shares Held

24,000

first reported quarter

Ownership

0.041%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#93

of 238 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Skandinaviska Enskilda Banken AB (publ) holds $26,512,520 across 3 Biotechnology names. ACLX ranks #3 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	46,000	$20,540,840
2	DAWN	Day One Biopharmaceuticals, Inc.	150,000	$3,216,000
3	ACLX	Arcellx, Inc. This page	24,000	$2,755,680

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,755,680	24,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.